newsfilter
← Interviews
Sourcery with Molly O'Shea39 min

The Quiet Revolution in DNA Sequencing | Nucleus Genomics

Molly O'Shea, Kian Sadeghi

Interview, Fireside Chat, Product Demonstration

Nucleus Genomics, backed by investors including Alexis Ohanian and Peter Thiel's Founders Fund, has launched its $399 whole-genome sequencing service to build a trillion-dollar consumer healthcare platform that integrates genetic data with wearable and clinical inputs. Led by Kian Sadegi, the company differentiates itself from competitors by utilizing full genome sequencing rather than SNP-based chips to offer features like the Nucleus IQ polygenic score while maintaining strict data privacy controls. With a roadmap to sequence 500,000 samples within two years, Nucleus aims to disrupt the stagnant genomics market by providing direct consumer access to comprehensive health insights and expanding disease analysis from twenty to hundreds of conditions.